novo nordisk semaglutide clinical trials Finishing my 72-week trial (Novo STEP-UP) : r/Semaglutide Latest Competitive Analysis of Novo
Description
In other words: this isnt a peak, its a new baseline

Peptides 32 , 3643 (2011)
Semaglutide Injection Dosage 4.02 mg/3 ml Semaglutide Injection Dosage 4.02 mg/3 ml strength is widely used as a starter dose or for patients requiring moderate GLP1 activity
Semaglutide GLP-1 belongs to a category of medications known as GLP-1 receptor agonists, which mimic the glucagon-like peptide-1 hormone that regulates feelings of fullness after eating
:max_bytes(150000):strip_icc()/GettyImages-2186482541-b5eda0fcf8804c42a77ef0d338260a7e.jpg)